An evaluation of current cholera treatment

Expert Opinion on Pharmacotherapy

Volumn 4, Issue 2, 2003, Pages 141-146

  Bhattacharya, Sujit Kumar ^a  

^a NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

Author keywords

Cholera; Ciprofloxacin; Doxycycline; Drug resistance; Furazolidone; Norfloxacin; Oral rehydration salt solution; Ringer's lactate; Tetracycline

Indexed keywords

AMPICILLIN; ANTIAMEBIC AGENT; ANTIBIOTIC AGENT; ANTIDIARRHEAL AGENT; ATROPINE; ATTAPULGITE; CHLORAMPHENICOL; CHOLERA VACCINE; CIPROFLOXACIN; CODEINE; COLESTYRAMINE; COTRIMOXAZOLE; DIPHENOXYLATE; DOXYCYCLINE; ELECTROLYTE; ERYTHROMYCIN; FURAZOLIDONE; KAOLIN; LOPERAMIDE; METRONIDAZOLE; NALIDIXIC ACID; NORFLOXACIN; OPIATE; ORAL REHYDRATION SOLUTION; PECTIN; RINGER LACTATE SOLUTION; STOMACH SECRETION INHIBITOR; TETRACYCLINE; TINIDAZOLE; UNINDEXED DRUG;

ADULT; BACTERIAL STRAIN; CHILD; CHOLERA; DEHYDRATION; DIARRHEA; DISEASE SEVERITY; DOSE RESPONSE; DRUG ACCUMULATION; DRUG EFFICACY; DRUG SAFETY; ELECTROLYTE EXCRETION; FEEDING; HOSPITALIZATION; HUMAN; ORAL REHYDRATION THERAPY; REHYDRATION; REVIEW; TOOTH DISEASE; VIBRIO CHOLERAE; VOMITING;

ANTI-INFECTIVE AGENTS; CHOLERA; DEHYDRATION; DIARRHEA; DRUG RESISTANCE, BACTERIAL; FLUID THERAPY; HUMANS; REHYDRATION SOLUTIONS;

EID: 0037324357     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.4.2.141     Document Type: Review

References (27)

1. BARUA D: History of Cholera. In: Cholera. Barua D and Greenough WB III (Eds) Plenum Medcal Book Company, New York and London (1992):1-35.
2. GANGAROSA EJ, TAUXE RV: Epilogue: the Latin Amercan cholera epidemic. In: Cholera. Barua D and Greenough WB III (Ed.) Plenum Medcal Book Company, New York and London (1992):351-357.
3. RAMAMURTHY T, GARG S, SHARMA R et al.: Emergence of novel strain of Vibrio cholerae with epidemic potential in Southern and Eastern India. Lancet (1993) 341:703-704.
4. NAIR GB, RAMAMURTHY T, BHATTACHARYA SK et al.: Spread of Vibrio cholerae O139 Bengal in India. Infect. Dis. (1994) 169:1029-1034.
5. BHATTACHARYA SK, GOSWAMI AG, BHATTACHARYA MK et al.: Epidemic of Vibrio cholerae O139 in Calcutta. Ind. J. Med. Res. (1994) 100:213-216.
6. BHATTACHARYA SK, BHATTACHARYA MK, NAIR GB et al.: Clinical profile of acute diarrhoeal cases infected with the new epidemic strain of V. cholerae O139: designation of the disease as cholera. J. Infect. (1993) 27:11-15.
7. Diarrhoeal Diseases Control Programme (CDD). The treatment of diarrhoea - a manual for physicians and other senior health workers. (WHO/CDR/95.3).
8. Water with sugar and salt. Lancet (1978) 2:300.
9. PHILIPS RA: Water and electrolyte losses in cholera. Fed. Proc. (1964) 23:705-712.
10. HIRSCHHORN N, KINZIE JL, SACHAR DB et al.: Decrease in net stool output in cholera during intestinal perfusion with glucose containing solution. N. Engl. J. Med. (1968) 279:176-181.
11. NALIN DR, CASH RA, ISLAM R, MOLLA M, PHILLIPS RA: Oral maintenance therapy for cholera in adults. Lancet (1968) 2:370-373.
12. CASH RA, NALIN DR, ROCHAT R, RELLER LB, HAQUE ZA, RAHMAN AS: A clinical trial of oral therapy in a rural cholera treatment center. Am. J. Trop. Med. Hyg. (1970) 19:653-656.
13. GORE SM, FONTAINE O, PIERCE NF: Impact of rice based oral rehydration solution on stool output and duration of diarrhoea: meta-analysis of 13 clinical trials. Br. Med. J. (1992) 304:287-291.
14. WHO Expert Consultation on Oral Rehydration Salts (ORS) Formulation. WHO/UNICEF, UNICEF House, New York, USA. WHO/FCH/CAH/01.22.
15. RAHMAN O, BENNISH ML, ALAM AN, SALAM MA: Rapid intravenous rehydration by means of a single polyelectrolyte solution with or without dextrose. J. Pediatr. (1988) 113(4):654-660.
16. CARPENTER CCJ, BARUA D, SACK RB et al.: Clinical studies on Asiatic cholera, IV. Antibiotic therapy in cholera. Bull. Johns Hopkins Hosp. (1986) 118:230-242.
17. DE S, CHOWDHURI A, DUTTA P et al.: Doxycycline in the treatment of cholera. Bull. Wld. Hlth. Org. (1975) 54:177-179.
18. BHATTACHARYA SK, BHATTACHARYA MK, DUTTA P et al.: Double-blind, randomized, controlled clinical trial of norfloxacin for cholera. Antimicrob. Agents Chemother. (1990) 34:939-940.
19. GOTUZZO E, SEAS C, ECHEVARRIA J et al.: Ciprofloxacin for the treatment of cholera: a randomized, double-blind, controlled clinical trial of a single daily dose in Peruvian adults. Clin. Infect. Dis. (1995) 20:1485-1490.
20. GARG P, CHAKRABORTY S, BASU I et al.: Expanding multiple antibiotic resistance among clinical staining of Vibrio cholerae isolated from 1992-7 in Calcutta, India. Epidemiol. Infect. (2000) 124:393-399.
21. GARG P, SINHA S, CHAKRABORTY R et al.: Emergence of fluoroquinolone-resistant strains of Vibrio cholerae O1 biotype ElTor among hospitalized patients with cholera in Calcutta, India. Antimicrob. Agents Chemother. (2001) 45:1605-1606.
22. BHATTACHARYA SK, BHATTACHARYA MK, DUTTA D et al.: The rational use of drugs in the treatment of acute diarrhoea. J. Assoc. Phys. India (1994) 42:503-505.
23. RABBANI GH: Mechanism and treatment of diarrhoea due to Vibrio cholerae and Escherichia coli: roles of drugs and prostaglandins. Dan. Med. Bull. (1996) 43(2):173-185.
24. CEZARD JP, DUHAMEL JF, MEYER M et al.: Efficacy and tolerability of racecadotril in acute diarrhoea in children. Gastroenterologv (2001) 120(4):799-805.
25. AHMED T, ALI M, ULLAH MM et al.: Mortality in severely malnourished children with diarrhoea and use of a standardized management protocol. Lancet (1999) 353(9168):1919-1922.
26. FONTAINE O: Effect of zinc supplementation on clinical course of acute diarrhoea. J. Health Popul. Nutr. (2001) 19(4):339-346.
27. Guidelines for Cholera Control. World Health Organization, Geneva, 1993.